Brief: Index Pharmaceuticals Announces License Agreement With Viatris Japan To Develop And Commercialize Cobitolimod In Japan

Flerie AB

31/05/2023 17:36

May 31 (Reuters) - InDex Pharmaceuticals Holding AB
 INDEX.ST :
    * INDEX PHARMACEUTICALS ANNOUNCES LICENSE AGREEMENT WITH
VIATRIS
JAPAN TO DEVELOP AND COMMERCIALIZE COBITOLIMOD IN JAPAN
    * INDEX PHARMACEUTICALS HOLDING AB SAYS AGREEMENT INCLUDING
MILESTONES IS WORTH UP TO USD$50M, EXCLUDING ROYALTIES

Source text for Eikon:  ID:nWkr1WsPyQ 
Further company coverage:  INDEX.ST 

 ((Reuters.Briefs@thomsonreuters.com;))